Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Phase 1 study of lenalidomide plus dose-adjusted EPOCH-R in patients with aggressive B-cell lymphomas with deregulated MYC and BCL2.

Godfrey JK, Nabhan C, Karrison T, Kline JP, Cohen KS, Bishop MR, Stadler WM, Karmali R, Venugopal P, Rapoport AP, Smith SM.

Cancer. 2019 Jun 1;125(11):1830-1836. doi: 10.1002/cncr.31877. Epub 2019 Feb 1.

PMID:
30707764
2.

University of Chicago phase II consortium trial of selumetinib (MEKi) demonstrates low tolerability and efficacy in relapsed DLBCL.

Galanina N, Smith SM, Liao C, Petrich A, Libao B, Gartenhaus R, Westin JR, Cohen KS, Knost JA, Stadler WM, Doyle A, Karrison T, Gordon LI, Evens AM.

Br J Haematol. 2018 Apr;181(2):264-267. doi: 10.1111/bjh.14544. Epub 2017 Apr 17. No abstract available.

3.

Therapeutic activity of high-dose intratumoral IFN-╬▓ requires direct effect on the tumor vasculature.

Spaapen RM, Leung MY, Fuertes MB, Kline JP, Zhang L, Zheng Y, Fu YX, Luo X, Cohen KS, Gajewski TF.

J Immunol. 2014 Oct 15;193(8):4254-60. doi: 10.4049/jimmunol.1401109. Epub 2014 Sep 12.

4.

Association of circulating endothelial microparticles with cardiometabolic risk factors in the Framingham Heart Study.

Amabile N, Cheng S, Renard JM, Larson MG, Ghorbani A, McCabe E, Griffin G, Guerin C, Ho JE, Shaw SY, Cohen KS, Vasan RS, Tedgui A, Boulanger CM, Wang TJ.

Eur Heart J. 2014 Nov 7;35(42):2972-9. doi: 10.1093/eurheartj/ehu153. Epub 2014 Apr 16.

5.

Circulating CD31+ leukocyte frequency is associated with cardiovascular risk factors.

Ge Y, Cheng S, Larson MG, Ghorbani A, Martin RP, Klein RJ, O'Donnell CJ, Vasan RS, Shaw SY, Wang TJ, Cohen KS.

Atherosclerosis. 2013 Jul;229(1):228-33. doi: 10.1016/j.atherosclerosis.2013.04.017. Epub 2013 Apr 22.

6.

Circulating CD34(+) progenitor cell frequency is associated with clinical and genetic factors.

Cohen KS, Cheng S, Larson MG, Cupples LA, McCabe EL, Wang YA, Ngwa JS, Martin RP, Klein RJ, Hashmi B, Ge Y, O'Donnell CJ, Vasan RS, Shaw SY, Wang TJ.

Blood. 2013 Feb 21;121(8):e50-6. doi: 10.1182/blood-2012-05-424846. Epub 2013 Jan 3.

7.

Critical role for the receptor tyrosine kinase EPHB4 in esophageal cancers.

Hasina R, Mollberg N, Kawada I, Mutreja K, Kanade G, Yala S, Surati M, Liu R, Li X, Zhou Y, Ferguson BD, Nallasura V, Cohen KS, Hyjek E, Mueller J, Kanteti R, El Hashani E, Kane D, Shimada Y, Lingen MW, Husain AN, Posner MC, Waxman I, Villaflor VM, Ferguson MK, Varticovski L, Vokes EE, Gill P, Salgia R.

Cancer Res. 2013 Jan 1;73(1):184-94. doi: 10.1158/0008-5472.CAN-12-0915. Epub 2012 Oct 24. Erratum in: Cancer Res. 2013 Jul 15;73(14):4594.

8.

Cellular and molecular requirements for rejection of B16 melanoma in the setting of regulatory T cell depletion and homeostatic proliferation.

Kline J, Zhang L, Battaglia L, Cohen KS, Gajewski TF.

J Immunol. 2012 Mar 15;188(6):2630-42. doi: 10.4049/jimmunol.1100845. Epub 2012 Feb 6.

9.

Circulating angiogenic cell populations, vascular function, and arterial stiffness.

Cheng S, Wang N, Larson MG, Palmisano JN, Mitchell GF, Benjamin EJ, Vasan RS, Levy D, McCabe EL, Vita JA, Wang TJ, Shaw SY, Cohen KS, Hamburg NM.

Atherosclerosis. 2012 Jan;220(1):145-50. doi: 10.1016/j.atherosclerosis.2011.10.015. Epub 2011 Oct 20.

10.

Safety, Efficacy, and Biomarker Exploration in a Phase II Study of Bevacizumab, Oxaliplatin, and Gemcitabine in Recurrent M├╝llerian Carcinoma.

Horowitz NS, Penson RT, Duda DG, di Tomaso E, Boucher Y, Ancukiewicz M, Cohen KS, Berlin S, Krasner CN, Moses MA, Jain RK.

Clin Ovarian Cancer Other Gynecol Malig. 2011 Jun;4(1):26-33.

11.

Angiogenesis and multiple myeloma: is there a role for angiogenic biomarkers in the context of autologous stem cell transplant?

Cohen KS.

Leuk Lymphoma. 2011 Jul;52(7):1173-5. doi: 10.3109/10428194.2011.591009. No abstract available.

PMID:
21699381
12.

Genetic and clinical correlates of early-outgrowth colony-forming units.

Shaw SY, Cheng S, Cupples LA, Larson MG, McCabe EL, Ngwa JS, Wang YA, Martin RP, Klein RJ, Hashmi B, Ajijola OA, Lau E, O'Donnell CJ, Vasan RS, Cohen KS, Wang TJ.

Circ Cardiovasc Genet. 2011 Jun;4(3):296-304. doi: 10.1161/CIRCGENETICS.110.958470. Epub 2011 Apr 14.

13.

T-cell-depleted allogeneic transplant without donor leukocyte infusions results in excellent long-term survival in patients with multiply relapsed Lymphoma. Predictors for survival after transplant relapse.

Kenkre VP, Horowitz S, Artz AS, Liao C, Cohen KS, Godley LA, Kline JP, Smith SM, Stock W, van Besien K.

Leuk Lymphoma. 2011 Feb;52(2):214-22. doi: 10.3109/10428194.2010.538777. Epub 2010 Dec 10.

14.

Association of colony-forming units with coronary artery and abdominal aortic calcification.

Cheng S, Cohen KS, Shaw SY, Larson MG, Hwang SJ, McCabe EL, Martin RP, Klein RJ, Hashmi B, Hoffmann U, Fox CS, Vasan RS, O'Donnell CJ, Wang TJ.

Circulation. 2010 Sep 21;122(12):1176-82. doi: 10.1161/CIRCULATIONAHA.109.931279. Epub 2010 Sep 7.

15.

The impact of MYC expression in lymphoma biology: beyond Burkitt lymphoma.

Smith SM, Anastasi J, Cohen KS, Godley LA.

Blood Cells Mol Dis. 2010 Dec 15;45(4):317-23. doi: 10.1016/j.bcmd.2010.08.002. Epub 2010 Sep 6. Review.

PMID:
20817505
16.

Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma.

Batchelor TT, Duda DG, di Tomaso E, Ancukiewicz M, Plotkin SR, Gerstner E, Eichler AF, Drappatz J, Hochberg FH, Benner T, Louis DN, Cohen KS, Chea H, Exarhopoulos A, Loeffler JS, Moses MA, Ivy P, Sorensen AG, Wen PY, Jain RK.

J Clin Oncol. 2010 Jun 10;28(17):2817-23. doi: 10.1200/JCO.2009.26.3988. Epub 2010 May 10.

17.

Blockade of tumor necrosis factor alpha signaling in tumor-associated macrophages as a radiosensitizing strategy.

Meng Y, Beckett MA, Liang H, Mauceri HJ, van Rooijen N, Cohen KS, Weichselbaum RR.

Cancer Res. 2010 Feb 15;70(4):1534-43. doi: 10.1158/0008-5472.CAN-09-2995. Epub 2010 Feb 9.

18.

VEGFR2+PDGFRbeta+ circulating precursor cells participate in capillary restoration after hyperoxia acute lung injury (HALI).

Jones R, Capen DE, Jacobson M, Cohen KS, Scadden DT, Duda DG.

J Cell Mol Med. 2009 Sep;13(9B):3720-9. doi: 10.1111/j.1582-4934.2009.00785.x. Epub 2009 May 6.

19.

Normal ovarian surface epithelial label-retaining cells exhibit stem/progenitor cell characteristics.

Szotek PP, Chang HL, Brennand K, Fujino A, Pieretti-Vanmarcke R, Lo Celso C, Dombkowski D, Preffer F, Cohen KS, Teixeira J, Donahoe PK.

Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):12469-73. doi: 10.1073/pnas.0805012105. Epub 2008 Aug 18. Erratum in: Proc Natl Acad Sci U S A. 2008 Dec 2;105(48):19024.

20.

A protocol for phenotypic detection and characterization of vascular cells of different origins in a lung neovascularization model in rodents.

Jones RC, Capen DE, Cohen KS, Munn LL, Jain RK, Duda DG.

Nat Protoc. 2008;3(3):388-97. doi: 10.1038/nprot.2007.537.

21.

At the canyon's edge: depression in American Indian culture.

Cohen KS.

Explore (NY). 2008 Mar-Apr;4(2):127-35. doi: 10.1016/j.explore.2007.12.004. No abstract available.

PMID:
18316056
22.

Differential in vivo potential of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood to form functional long-lasting vessels.

Au P, Daheron LM, Duda DG, Cohen KS, Tyrrell JA, Lanning RM, Fukumura D, Scadden DT, Jain RK.

Blood. 2008 Feb 1;111(3):1302-5. Epub 2007 Nov 9.

23.

Complete pathological response to bevacizumab and chemoradiation in advanced rectal cancer.

Willett CG, Duda DG, di Tomaso E, Boucher Y, Czito BG, Vujaskovic Z, Vlahovic G, Bendell J, Cohen KS, Hurwitz HI, Bentley R, Lauwers GY, Poleski M, Wong TZ, Paulson E, Ludwig KA, Jain RK.

Nat Clin Pract Oncol. 2007 May;4(5):316-21.

25.

Therapeutic targeting of a stem cell niche.

Adams GB, Martin RP, Alley IR, Chabner KT, Cohen KS, Calvi LM, Kronenberg HM, Scadden DT.

Nat Biotechnol. 2007 Feb;25(2):238-43. Epub 2007 Jan 21. Erratum in: Nat Biotechnol. 2007 Aug;25(8):944. Nat Biotechnol. 2008 Feb;26(2):241.

PMID:
17237769
26.

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.

Batchelor TT, Sorensen AG, di Tomaso E, Zhang WT, Duda DG, Cohen KS, Kozak KR, Cahill DP, Chen PJ, Zhu M, Ancukiewicz M, Mrugala MM, Plotkin S, Drappatz J, Louis DN, Ivy P, Scadden DT, Benner T, Loeffler JS, Wen PY, Jain RK.

Cancer Cell. 2007 Jan;11(1):83-95.

27.
29.

Evidence for incorporation of bone marrow-derived endothelial cells into perfused blood vessels in tumors.

Duda DG, Cohen KS, Kozin SV, Perentes JY, Fukumura D, Scadden DT, Jain RK.

Blood. 2006 Apr 1;107(7):2774-6. Epub 2005 Dec 8.

30.

Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients.

Willett CG, Boucher Y, Duda DG, di Tomaso E, Munn LL, Tong RT, Kozin SV, Petit L, Jain RK, Chung DC, Sahani DV, Kalva SP, Cohen KS, Scadden DT, Fischman AJ, Clark JW, Ryan DP, Zhu AX, Blaszkowsky LS, Shellito PC, Mino-Kenudson M, Lauwers GY.

J Clin Oncol. 2005 Nov 1;23(31):8136-9. No abstract available.

PMID:
16258121
31.

Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo.

Stroh M, Zimmer JP, Duda DG, Levchenko TS, Cohen KS, Brown EB, Scadden DT, Torchilin VP, Bawendi MG, Fukumura D, Jain RK.

Nat Med. 2005 Jun;11(6):678-82. Epub 2005 May 8.

32.

Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer.

Willett CG, Boucher Y, di Tomaso E, Duda DG, Munn LL, Tong RT, Chung DC, Sahani DV, Kalva SP, Kozin SV, Mino M, Cohen KS, Scadden DT, Hartford AC, Fischman AJ, Clark JW, Ryan DP, Zhu AX, Blaszkowsky LS, Chen HX, Shellito PC, Lauwers GY, Jain RK.

Nat Med. 2004 Feb;10(2):145-7. Epub 2004 Jan 25. Erratum in: Nat Med. 2004 Jun;10(6):649.

33.

The effects of tibial malrotation on the biomechanics of the tibiotalar joint.

Svoboda SJ, McHale K, Belkoff SM, Cohen KS, Klemme WR.

Foot Ankle Int. 2002 Feb;23(2):102-6.

PMID:
11858328
34.

An indigenous perspective on "Medicine and story".

Cohen KS.

Adv Mind Body Med. 2001 Spring;17(2):87-9. No abstract available.

PMID:
11400698
35.

Taoists eat their words, too.

Cohen KS.

Altern Ther Health Med. 1999 Jan;5(1):18. No abstract available.

PMID:
9893310
36.

Enteric beta-defensin: molecular cloning and characterization of a gene with inducible intestinal epithelial cell expression associated with Cryptosporidium parvum infection.

Tarver AP, Clark DP, Diamond G, Russell JP, Erdjument-Bromage H, Tempst P, Cohen KS, Jones DE, Sweeney RW, Wines M, Hwang S, Bevins CL.

Infect Immun. 1998 Mar;66(3):1045-56. Erratum in: Infect Immun 1998 May;66(5):2399.

37.

Sarcoidosis and beryllium exposure.

Cohen KS.

West J Med. 1995 Oct;163(4):396. No abstract available.

38.

Nucleotide sequence of murine PCNA: interspecies comparison of the cDNA and the 5' flanking region of the gene.

Shipman-Appasamy PM, Cohen KS, Prystowsky MB.

DNA Seq. 1991;2(3):181-91.

PMID:
1726365
39.
40.

Choose life: Jewish tradition and organ transplantation.

Cohen KS.

Del Med J. 1988 Sep;60(9):509-11. No abstract available.

PMID:
3181547
41.

Custom TOXFILE can offer low-cost toxicological data base.

Cohen KS.

Occup Health Saf. 1984 May:49-51. No abstract available.

PMID:
6547520
42.

Hidden chemical dangers may exist despite safety precautions.

Cohen KS.

Occup Health Saf. 1984 Feb:38-9. No abstract available.

PMID:
6709253
43.

Hazardous material information resources.

Cohen KS.

Occup Health Saf. 1983 Feb;52(2):15-7. No abstract available.

PMID:
6340013
44.

Health and safety consultants: uses and abuses.

Cohen KS.

Occup Health Saf. 1982 Nov;51(11):10-2. No abstract available.

PMID:
7167251
45.

The videotape revolution.

Cohen KS.

Occup Health Saf. 1982 Jul;51(7):9-12. No abstract available.

PMID:
7121954
46.

Techniques to improve the seating of castings.

Eames WB, O'Neal SJ, Monteiro J, Miller C, Roan JD Jr, Cohen KS.

J Am Dent Assoc. 1978 Mar;96(3):432-7.

PMID:
342584
47.

Pigs, new program aid transition to clinic.

Cohen KS.

Dent Stud. 1975 Oct;54(1):65. No abstract available.

PMID:
1068922
48.

A product report on a dispersed phase amalgam.

Eames WB, Cohen KS.

J Ga Dent Assoc. 1974 Spring;47(4):22-7. No abstract available.

PMID:
4530040
49.

Spherical alloy 1974: a status report.

Eames WB, Cohen KS.

J Ga Dent Assoc. 1973 Autumn;47(2):24-8. No abstract available.

PMID:
4520741

Supplemental Content

Loading ...
Support Center